[Federal Register Volume 89, Number 4 (Friday, January 5, 2024)]
[Notices]
[Pages 774-775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00050]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense (DoD).
ACTION: Notice of Federal Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: The DoD is publishing this notice to announce that the
following Federal Advisory Committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (UFBAP) will take place.
DATES: Open to the public Wednesday, January 3, 2024, 10:00 a.m. to
1:00 p.m. (Eastern Standard Time).
ADDRESSES: The meeting will be held telephonically or via conference
call. The phone number for the remote access on January 3, 2024, is:
CONUS: 1-800-369-2046; OCONUS: 1-203-827-7030; PARTICIPANT CODE:
8546285.
These numbers and the dial-in instructions will also be posted on
the UFBAP website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.
FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO)
Colonel Paul B. Carby, USA, 703-681-2890 (voice), [email protected] (email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting
agenda can be found on the website.
SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of
the Designated Federal Officer, the Uniform Formulary Beneficiary
Advisory Panel was unable to provide public notification required by 41
CFR 102-3.150(a) concerning its January 3, 2024 meeting. Accordingly,
the Advisory Committee Management Officer for the Department of
Defense, pursuant to 41
[[Page 775]]
CFR 102-3.150(b), waives the 15-calendar day notification requirement.
This meeting is being held under the provisions of 5 United States
Code (U.S.C.) chapter 10 (commonly known as the Federal Advisory
Committee Act or FACA), the Government in the Sunshine Act of 1976 (5
U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
Purpose of the Meeting: The UFBAP will review and comment on
recommendations made by the Pharmacy and Therapeutics Committee to the
Director, Defense Health Agency regarding the Uniform Formulary.
Agenda:
1. 10:00 a.m. Sign In for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UFBAP Members by
COL Paul B. Carby, DFO, UFBAP
b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP
c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair
d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
a. Closing Remarks by UFBAP Co-Chair
b. Closing Remarks by DFO, UFBAP
Meeting Accessibility: Pursuant to section 1009(a)(1) of the FACA
and 41 CFR 102-3.140 through 102-3.165, and subject to the availability
of phone lines, this meeting is open to the public. Telephone lines are
limited and available to the first 220 people dialing in. There will be
220 lines total: 200 domestic and 20 international, including leader
lines.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons
or organizations may submit written statements to the UFBAP about its
mission and/or the agenda to be addressed in this public meeting.
Written statements should be submitted to the UFBAP's DFO. The DFO's
contact information can be found in the FOR FURTHER INFORMATION CONTACT
section of this notice. Written comments or statements must be received
by the UFBAP's DFO no later than 8:00 a.m. EST, Wednesday, January 3,
2024, so they may be made available to the UFBAP for its consideration
prior to the meeting. Written comments received are releasable to the
public. The DFO will review all submitted written statements and
provide copies to UFBAP.
Dated: January 2, 2024.
Natalie M. Ragland,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-00050 Filed 1-2-24; 4:15 pm]
BILLING CODE 6001-FR-P